Jundishapur Journal of Microbiology

Published by: Kowsar

Co-Expression of hbha and mtb32C Genes from Mycobacterium tuberculosis H37Rv in a Prokaryotic System

Roghaye Teimourpour 1 , Hadi Peeridogaheh 1 , Mohsen Arzanlou 1 , Aida Gholoobi 3 , Mojtaba Sankian 4 and Zahra Meshkat 2 , *
Authors Information
1 Department of Microbiology, School of Medicine, Ardabil University of Medical Sciences, Ardabil, IR Iran
2 Antimicrobial Resistance Research Center, Mashhad University of Medical Sciences, Mashhad, IR Iran
3 Department of Modern Sciences and Technologies, School of Medicine, Mashhad University of Medical Sciences, Mashhad, IR Iran
4 Department of Immunology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, IR Iran
Article information
  • Jundishapur Journal of Microbiology: February 2018, 11 (2); e14030
  • Published Online: January 13, 2018
  • Article Type: Research Article
  • Received: May 24, 2017
  • Revised: November 8, 2017
  • Accepted: December 16, 2017
  • DOI: 10.5812/jjm.14030

To Cite: Teimourpour R, Peeridogaheh H, Arzanlou M, Gholoobi A, Sankian M, et al. Co-Expression of hbha and mtb32C Genes from Mycobacterium tuberculosis H37Rv in a Prokaryotic System, Jundishapur J Microbiol. 2018 ; 11(2):e14030. doi: 10.5812/jjm.14030.

Copyright © 2018, Jundishapur Journal of Microbiology. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
6. Conclusions
  • 1. Organization WH. Global tuberculosis report. 2014. Available from: www.who.int/tb.
  • 2. Dara M, Dadu A, Kremer K, Zaleskis R, Kluge HH. Epidemiology of tuberculosis in WHO European Region and public health response. Eur Spine J. 2013;22 Suppl 4:549-55. doi: 10.1007/s00586-012-2339-3. [PubMed: 22565803].
  • 3. Yilmaz N, Zehra Aydin S, Inanc N, Karakurt S, Direskeneli H, Yavuz S. Comparison of QuantiFERON-TB Gold test and tuberculin skin test for the identification of latent Mycobacterium tuberculosis infection in lupus patients. Lupus. 2012;21(5):491-5. doi: 10.1177/0961203311430700. [PubMed: 22140142].
  • 4. Herrera V, Perry S, Parsonnet J, Banaei N. Clinical application and limitations of interferon-gamma release assays for the diagnosis of latent tuberculosis infection. Clin Infect Dis. 2011;52(8):1031-7. doi: 10.1093/cid/cir068. [PubMed: 21460320].
  • 5. Ribeiro-Guimaraes ML, Pessolani MC. Comparative genomics of mycobacterial proteases. Microb Pathog. 2007;43(5-6):173-8. doi: 10.1016/j.micpath.2007.05.010. [PubMed: 17611072].
  • 6. Rindi L, Lari N, Garzelli C. Search for genes potentially involved in Mycobacterium tuberculosis virulence by mRNA differential display. Biochem Biophys Res Commun. 1999;258(1):94-101. doi: 10.1006/bbrc.1999.0591. [PubMed: 10222241].
  • 7. Menozzi FD, Bischoff R, Fort E, Brennan MJ, Locht C. Molecular characterization of the mycobacterial heparin-binding hemagglutinin, a mycobacterial adhesin. Proc Natl Acad Sci U S A. 1998;95(21):12625-30. [PubMed: 9770536].
  • 8. Vidal Pessolani MC, Marques MA, Reddy VM, Locht C, Menozzi FD. Systemic dissemination in tuberculosis and leprosy: do mycobacterial adhesins play a role?. Microbes Infect. 2003;5(7):677-84. [PubMed: 12787744].
  • 9. Locht C, Hougardy JM, Rouanet C, Place S, Mascart F. Heparin-binding hemagglutinin, from an extrapulmonary dissemination factor to a powerful diagnostic and protective antigen against tuberculosis. Tuberculosis (Edinb). 2006;86(3-4):303-9. doi: 10.1016/j.tube.2006.01.016. [PubMed: 16510310].
  • 10. Guerrero GG, Feunou F P, Locht C. The coiled-coil N-terminal domain of the heparin-binding haemagglutinin is required for the humoral and cellular immune responses in mice. Mol Immunol. 2008;46(1):116-24. doi: 10.1016/j.molimm.2008.07.009.
  • 11. Sato K, Tomioka H, Shimizu T, Gonda T, Ota F, Sano C. Type II alveolar cells play roles in macrophage-mediated host innate resistance to pulmonary mycobacterial infections by producing proinflammatory cytokines. J Infect Dis. 2002;185(8):1139-47. doi: 10.1086/340040. [PubMed: 11930324].
  • 12. Rouanet C, Debrie AS, Lecher S, Locht C. Subcutaneous boosting with heparin binding haemagglutinin increases BCG-induced protection against tuberculosis. Microbes Infect. 2009;11(13):995-1001. doi: 10.1016/j.micinf.2009.07.005. [PubMed: 19635582].
  • 13. Guerrero GG, Locht C. Recombinant HBHA boosting effect on BCG-induced immunity against Mycobacterium tuberculosis infection. Clin Dev Immunol. 2011;2011:730702. doi: 10.1155/2011/730702. [PubMed: 21647410].
  • 14. Hougardy JM, Schepers K, Place S, Drowart A, Lechevin V, Verscheure V, et al. Heparin-binding-hemagglutinin-induced IFN-gamma release as a diagnostic tool for latent tuberculosis. PLoS One. 2007;2(10). e926. doi: 10.1371/journal.pone.0000926. [PubMed: 17912342].
  • 15. Bruggemann H, Gottschalk G. Insights in metabolism and toxin production from the complete genome sequence of Clostridium tetani. Anaerobe. 2004;10(2):53-68. doi: 10.1016/j.anaerobe.2003.08.001. [PubMed: 16701501].
  • 16. Skeiky YAW, Alderson MR, Ovendale PJ, Guderian JA, Brandt L, Dillon DC, et al. Differential Immune Responses and Protective Efficacy Induced by Components of a Tuberculosis Polyprotein Vaccine, Mtb72F, Delivered as Naked DNA or Recombinant Protein. J Immunol. 2004;172(12):7618-28. doi: 10.4049/jimmunol.172.12.7618.
  • 17. Masungi C, Temmerman S, Van Vooren JP, Drowart A, Pethe K, Menozzi FD, et al. Differential T and B cell responses against Mycobacterium tuberculosis heparin-binding hemagglutinin adhesin in infected healthy individuals and patients with tuberculosis. J Infect Dis. 2002;185(4):513-20. doi: 10.1086/338833. [PubMed: 11865404].
  • 18. Baghani A, Youssefi M, Safdari H, Teimourpour R, Meshkat Z. Designing and Construction Pcdna3.1 Vector Encoding Cfp10 Gene of Mycobacterium tuberculosis. Jundishapur J Microbiol. 2015;8(10). e23560. doi: 10.5812/jjm.23560. [PubMed: 26587210].
  • 19. Teimourpour R, Sadeghian A, Meshkat Z, Esmaelizad M, Sankian M, Jabbari AR. Construction of a DNA Vaccine Encoding Mtb32C and HBHA Genes of Mycobacterium tuberculosis. Jundishapur J Microbiol. 2015;8(8). e21556. doi: 10.5812/jjm.21556. [PubMed: 26464766].
  • 20. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. Cold spring harbor laboratory press; 1989.
  • 21. Skeiky YA, Alderson MR, Ovendale PJ, Guderian JA, Brandt L, Dillon DC, et al. Differential immune responses and protective efficacy induced by components of a tuberculosis polyprotein vaccine, Mtb72F, delivered as naked DNA or recombinant protein. J Immunol. 2004;172(12):7618-28. [PubMed: 15187142].
  • 22. van de Vosse E, Hoeve MA, Ottenhoff TH. Human genetics of intracellular infectious diseases: molecular and cellular immunity against mycobacteria and salmonellae. Lancet Infect Dis. 2004;4(12):739-49. doi: 10.1016/S1473-3099(04)01203-4. [PubMed: 15567123].
  • 23. Lamberti M, Uccello R, Monaco MGL, Muoio M, Feola D, Sannolo N, et al. Tuberculin skin test and Quantiferon test agreement and influencing factors in tuberculosis screening of healthcare workers: a systematic review and meta-analysis. J Occup Med Toxicol. 2015;10:2. doi: 10.1186/s12995-015-0044-y. [PubMed: 25670962].
  • 24. Druszczynska M, Kowalewicz-Kulbat M, Fol M, Wlodarczyk M, Rudnicka W. Latent M. tuberculosis infection--pathogenesis, diagnosis, treatment and prevention strategies. Pol J Microbiol. 2012;61(1):3-10. [PubMed: 22708341].
  • 25. Lalvani A, Pareek M. A 100 year update on diagnosis of tuberculosis infection. Br Med Bull. 2010;93:69-84. doi: 10.1093/bmb/ldp039. [PubMed: 19926636].
  • 26. Kunst H. Diagnosis of latent tuberculosis infection: the potential role of new technologies. Respir Med. 2006;100(12):2098-106. doi: 10.1016/j.rmed.2006.02.032. [PubMed: 16650976].
  • 27. Norton BL, Holland DP. Current management options for latent tuberculosis: a review. Infect Drug Resist. 2012;5:163-73. doi: 10.2147/IDR.S29180. [PubMed: 23226700].
  • 28. Nayak S, Acharjya B. Mantoux test and its interpretation. Indian Dermatol Online J. 2012;3(1):2-6. doi: 10.4103/2229-5178.93479. [PubMed: 23130251].
  • 29. Blumberg HM, Kempker RR. Interferon-gamma release assays for the evaluation of tuberculosis infection. JAMA. 2014;312(14):1460-1. doi: 10.1001/jama.2014.4928. [PubMed: 25291583].
  • 30. Dheda K, van Zyl-Smit RN, Meldau R, Meldau S, Symons G, Khalfey H, et al. Quantitative lung T cell responses aid the rapid diagnosis of pulmonary tuberculosis. Thorax. 2009;64(10):847-53. doi: 10.1136/thx.2009.116376. [PubMed: 19592392].
  • 31. Trajman A, Steffen RE, Menzies D. Interferon-gamma release assays versus tuberculin skin testing for the diagnosis of latent tuberculosis infection: an overview of the evidence. Pulm Med. 2013. 2013:601737. doi: 10.1155/2013/601737. [PubMed: 23476763].
  • 32. Pang CS, Shen YC, Tian PW, Zhu J, Feng M, Wan C, et al. Accuracy of the interferon-gamma release assay for the diagnosis of tuberculous pleurisy: an updated meta-analysis. PeerJ. 2015;3. e951. doi: 10.7717/peerj.951. [PubMed: 26038718].
  • 33. Host H, Drobecq H, Locht C, Menozzi FD. Enzymatic methylation of the Mycobacterium tuberculosis heparin-binding haemagglutinin. FEMS Microbiol Lett. 2007;268(2):144-50. doi: 10.1111/j.1574-6968.2007.00636.x. [PubMed: 17263844].
  • 34. Kim KH, Yang CS, Shin AR, Jeon SR, Park JK, Kim HJ, et al. Mycobacterial Heparin-binding Hemagglutinin Antigen Activates Inflammatory Responses through PI3-K/Akt, NF-kappaB, and MAPK Pathways. Immune Netw. 2011;11(2):123-33. doi: 10.4110/in.2011.11.2.123. [PubMed: 21637390].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments